Henry Schein Pre-Tax Profit Margin 2010-2024 | HSIC

Current and historical pre-tax profit margin for Henry Schein (HSIC) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Henry Schein pre-tax profit margin for the three months ending March 31, 2024 was .
Henry Schein Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $12.45B $0.51B 4.06%
2023-12-31 $12.34B $0.54B 4.39%
2023-09-30 $12.69B $0.59B 4.66%
2023-06-30 $12.60B $0.62B 4.90%
2023-03-31 $12.53B $0.65B 5.15%
2022-12-31 $12.65B $0.72B 5.70%
2022-09-30 $12.61B $0.85B 6.76%
2022-06-30 $12.72B $0.85B 6.71%
2022-03-31 $12.66B $0.84B 6.67%
2021-12-31 $12.40B $0.83B 6.70%
2021-09-30 $12.24B $0.81B 6.60%
2021-06-30 $11.90B $0.78B 6.54%
2021-03-31 $10.62B $0.56B 5.25%
2020-12-31 $10.12B $0.50B 4.94%
2020-09-30 $9.62B $0.52B 5.39%
2020-06-30 $9.29B $0.52B 5.61%
2020-03-31 $10.06B $0.69B 6.85%
2019-12-31 $9.99B $0.68B 6.81%
2019-09-30 $9.79B $0.63B 6.44%
2019-06-30 $9.64B $0.56B 5.78%
2019-03-31 $9.51B $0.55B 5.77%
2018-12-31 $9.42B $0.54B 5.69%
2018-09-30 $6.69B $0.43B 6.46%
2018-06-30 $7.49B $0.53B 7.09%
2018-03-31 $8.23B $0.59B 7.18%
2017-12-31 $8.88B $0.63B 7.09%
2017-09-30 $12.26B $0.80B 6.54%
2017-06-30 $11.97B $0.79B 6.63%
2017-03-31 $11.78B $0.77B 6.51%
2016-12-31 $11.57B $0.76B 6.53%
2016-09-30 $11.30B $0.75B 6.60%
2016-06-30 $11.12B $0.74B 6.61%
2016-03-31 $10.88B $0.74B 6.78%
2015-12-31 $10.63B $0.72B 6.78%
2015-09-30 $10.48B $0.72B 6.91%
2015-06-30 $10.42B $0.71B 6.81%
2015-03-31 $10.41B $0.71B 6.82%
2014-12-31 $10.37B $0.71B 6.85%
2014-09-30 $10.20B $0.70B 6.84%
2014-06-30 $9.92B $0.69B 6.92%
2014-03-31 $9.70B $0.68B 7.01%
2013-12-31 $9.56B $0.67B 6.96%
2013-09-30 $9.44B $0.66B 6.94%
2013-06-30 $9.33B $0.64B 6.88%
2013-03-31 $9.13B $0.62B 6.78%
2012-12-31 $8.94B $0.61B 6.77%
2012-09-30 $8.87B $0.59B 6.63%
2012-06-30 $8.75B $0.58B 6.65%
2012-03-31 $8.68B $0.58B 6.67%
2011-12-31 $8.53B $0.57B 6.67%
2011-09-30 $8.22B $0.55B 6.66%
2011-06-30 $8.00B $0.54B 6.74%
2011-03-31 $7.72B $0.52B 6.79%
2010-12-31 $7.53B $0.50B 6.67%
2010-09-30 $7.29B $0.50B 6.85%
2010-06-30 $7.05B $0.48B 6.79%
2010-03-31 $6.81B $0.46B 6.81%
2009-12-31 $6.54B $0.45B 6.93%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.184B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00